Usana Health Sciences (USNA) Non Operating Interest Expenses (2010 - 2026)

Usana Health Sciences (USNA) has reported Non Operating Interest Expenses for 16 consecutive years, with $240000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 41.61% year-over-year to $240000.0 in Q2 2026; TTM through Jul 2026 was $412000.0, a 51.42% decrease from a year earlier, with the FY2026 full-year figure at $842000.0, up 199.64% from the prior year.
• Non Operating Interest Expenses was $240000.0 for Q2 2026 at Usana Health Sciences, up from $123000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $411000.0 in Q1 2025 and troughed at -$1.6 million in Q1 2022.
• A 5-year average of $14388.9 and a median of $50000.0 in 2024 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 55.21% in 2023 and soared 690.38% in 2025, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $32000.0 in 2022, then soared by 353.12% to $145000.0 in 2023, then decreased by 11.03% to $129000.0 in 2024, then plunged by 62.02% to $49000.0 in 2025, then soared by 389.8% to $240000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $240000.0 (Q2 2026), $123000.0 (Q1 2026), and $49000.0 (Q3 2025), per Business Quant data.